Cargando…
Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy
OBJECTIVE: Women with breast cancer (BCA) and cardiovascular disease (CVD) risk factors are at increased risk of developing cardiovascular complications when exposed to potentially cardiotoxic cancer therapy. The benefit of aggressive CVD risk factor modification to reduce adverse treatment-related...
Autores principales: | Fradley, Michael G., Alomar, Mohammed, Kilpatrick, Marcus W., Shields, Bernadette, Tran, Nhi, Best, Amey, Bianco, Erika, Armanious, Merna, Vautier, R. Ashton, Kip, Kevin, Beckie, Theresa M., Ismail-Khan, Roohi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166098/ https://www.ncbi.nlm.nih.gov/pubmed/34059163 http://dx.doi.org/10.1186/s40959-021-00107-w |
Ejemplares similares
-
Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020) -
Health care utilization and mortality associated with heart failure‐related admissions among cancer patients
por: Guha, Avirup, et al.
Publicado: (2019) -
Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies
por: Fradley, Michael G, et al.
Publicado: (2017) -
Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center Experience
por: Fradley, Michael G., et al.
Publicado: (2017) -
Bortezomib-Induced Complete Heart Block and Myocardial Scar: The Potential Role of Cardiac Biomarkers in Monitoring Cardiotoxicity
por: Diwadkar, Sachin, et al.
Publicado: (2016)